We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Late OOS Investigations Spur 483 for Ohio Drugmaker
Late OOS Investigations Spur 483 for Ohio Drugmaker
It took Luitpold Pharmaceuticals subsidiary PharmaForce in some instances months to close investigations into out-of-specification results, leading to a Form 483 from the FDA.